Cargando…
Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
The approval of histone deacetylase inhibitors for treatment of lymphoma subtypes has positioned histone modifications as potential targets for the development of new classes of anticancer drugs. Histones also undergo phosphorylation events, and Haspin is a protein kinase the only known target of wh...
Autores principales: | Huertas, D, Soler, M, Moreto, J, Villanueva, A, Martinez, A, Vidal, A, Charlton, M, Moffat, D, Patel, S, McDermott, J, Owen, J, Brotherton, D, Krige, D, Cuthill, S, Esteller, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312407/ https://www.ncbi.nlm.nih.gov/pubmed/21804608 http://dx.doi.org/10.1038/onc.2011.335 |
Ejemplares similares
-
Dissecting the roles of Haspin and VRK1 in histone H3 phosphorylation during mitosis
por: Cartwright, Tyrell N., et al.
Publicado: (2022) -
Identification and characterization of plant Haspin kinase as a histone H3 threonine kinase
por: Kurihara, Daisuke, et al.
Publicado: (2011) -
Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death
por: Bastea, Ligia I., et al.
Publicado: (2019) -
Untangling the contribution of Haspin and Bub1 to Aurora B function during mitosis
por: Hadders, Michael A., et al.
Publicado: (2020) -
SUMOylation of DNA topoisomerase IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis
por: Yoshida, Makoto M., et al.
Publicado: (2016)